| 10912744 |
Therapeutic formulation for reduced drug side effects |
— |
2021-02-09 |
| 10463633 |
Therapeutic formulation for reduced drug side effects |
— |
2019-11-05 |
| 9511037 |
Compositions for reduction of side effects |
— |
2016-12-06 |
| 7220434 |
Dual-release compositions of a cyclooxygenase-2 inhibitor |
Sreekant Nadkarni, Randy J. Wald, Gary DeBrincat |
2007-05-22 |
| 7172769 |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
Tugrul Kararli, Mark Kontny, Michael J. Hageman, Royal J. HASKELL, III |
2007-02-06 |
| 6103262 |
Modified-release metronidazole compositions and methods for making and using same |
Alan Mark Mancini, Steven C. Schumann |
2000-08-15 |
| 6030643 |
Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
Mark E. Adams, Aziz Karim, Kalidas Paul, Douglas J. Schaaf, David J. Zold |
2000-02-29 |
| 5756125 |
Controlled release naproxen sodium plus naproxen combination tablet |
— |
1998-05-26 |
| 5618559 |
Method of making modified-release metronidazole compositions |
Alan Mark Mancini, Steven C. Schumann |
1997-04-08 |
| 5609884 |
Controlled release naproxen sodium plus naproxen combination tablet |
— |
1997-03-11 |
| 4814178 |
Floating sustained release therapeutic compositions |
Sanford M. Bolton, Philip Izevbehai |
1989-03-21 |
| 4814179 |
Floating sustained release therapeutic compositions |
Sanford M. Bolton |
1989-03-21 |